World Journal of Cardiovascular Diseases

Volume 4, Issue 5 (May 2014)

ISSN Print: 2164-5329   ISSN Online: 2164-5337

Google-based Impact Factor: 0.38  Citations  

HIV Infection in Pregnancy and the Risk of Gestational Hypertension and Preeclampsia

HTML  XML Download Download as PDF (Size: 558KB)  PP. 257-267  
DOI: 10.4236/wjcd.2014.45034    4,039 Downloads   6,469 Views  Citations

ABSTRACT

The objective of this study was to evaluate the association between HIV infection and hypertensive disorders of pregnancy, comparing the rates of preeclampsia and gestational hypertension in a HIV-infected pregnant group and in a HIV-negative control pregnant group matched for age and parity. Furthermore, we aimed to compare the rates of hypertensive disorders in a subgroup of HIV-positive and HIV-negative African-American Black women. Patients and Methods: This was a prospective observational cohort study conducted at two University Departments of Obstetrics and Gynecology, Salesi Hospital, Ancona, and Sant’Orsola Hospital, Bologna. The HIV-infected patients’ group consisted of 126 pregnant women; 140 HIV-negative pregnant women matched for age and parity served as controls. Gestational hypertension and preeclampsia were diagnosed according to NHBPEP-ISSHP criteria. Categorical data were analyzed using the Fisher exact test. Statistical significance was set at a p value < 0.05. Results: Gestational hypertension and preeclampsia were diagnosed in 3 of 126 HIV-positive patients (2.38%) and in 14 of 140 HIV-negative patients (10%), with a relative risk of 0.24 (p = 0.0112). In the subgroup of African-American Black women, gestational hypertension and preeclampsia were diagnosed in 2 out of 43 HIV-positive (4.7%) and in 3 out of 18 HIV-negative patients (16.7%) with a relative risk of 0.28, not statistically significant (p = 0.1887). Conclusion: Pregnant women with HIV infection seem to be protected against gestational hypertension and preeclampsia and this protective effect remains also in a high risk population, such as African-American Black ethnic group. The effect is present independently from treatment received and virus copies. The lack of immune response present since the conception period should account for unopposed trophoblast invasion resulting in a better placentation.

Share and Cite:

Landi, B. , Bezzeccheri, V. , Guerra, B. , Piemontese, M. , Cervi, F. , Cecchi, L. , Margarito, E. , Giannubilo, S. , Ciavattini, A. and Tranquilli, A. (2014) HIV Infection in Pregnancy and the Risk of Gestational Hypertension and Preeclampsia. World Journal of Cardiovascular Diseases, 4, 257-267. doi: 10.4236/wjcd.2014.45034.

Cited by

[1] Appraisal of hepatocyte growth factor signal transduction in the duality of HIV associated pre-eclampsia
Pregnancy Hypertension, 2022
[2] Does HAART dysregulate angiogenesis in HIV infected preeclampsia?
Nigerian Journal of …, 2022
[3] Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus …
International Journal of …, 2022
[4] A Narrative Review of the Renin-Angiotensin-Aldosterone System in the Placenta and Placental Bed of HIV Infected Women of African Ancestry with …
Current Hypertension Reports, 2021
[5] The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia
2021
[6] The function of adipsin and C9 protein in the complement system in HIV-associated preeclampsia
2021
[7] HLA-G Polymorphisms Associated with HIV Infection and Preeclampsia in South Africans of African Ancestry
2020
[8] Prevalence and risk factors for pre-eclampsia/eclampsia in Northern Tanzania
2020
[9] The Role of Highly Active Antiretroviral Therapy (HAART) on Interleukin 17A (IL-17A) in Normotensive and Preeclamptic Black South African Women
2020
[10] The role of complement components C2 and C5a in HIV associated preeclampsia.
2020
[11] The regulation of sVEGFR-2 and sVEGFR-3 in the serum of pregnant women with HIV-related Pre-eclampsia recieving antiretroviral therapy.
2020
[12] The role of the complement system in HIV infection and preeclampsia
2019
[13] Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review
2019
[14] Human Immunodeficiency Virus and risk of Pre-eclampsia and Eclampsia in pregnant women: a meta-analysis on cohort studies
2019
[15] A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy
2019
[16] Maternal and perinatal outcomes after caesarean delivery in early and late onset preeclampsia with HIV positive and HIV negative South African Women
2019
[17] Urinary clusterin and glutathione-s-transferase levels in HIV positive normotensive and preeclamptic pregnancies
Hypertension in Pregnancy, 2018
[18] Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers
Inflammation Research, 2018
[19] Human infectious diseases and risk of preeclampsia: an updated review of the literature
Infection, 2017
[20] Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia
Expert Review of Medical Devices, 2017
[21] Lymphatic vascular endothelial hyaluronan receptor-1 immunoexpression in placenta of HIV infected pre-eclamptic women
Journal of Reproductive Immunology, 2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.